T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Fortinet
FTNT
$121B
| $77.1M | 0.01% |
3,808,385
+97,685
| +3% | +$2.09M |
|
|
TCDA
652
DELISTED
Tricida, Inc. Common Stock
TCDA
| $76.8M | 0.01% |
3,490,263
-938,955
| -21% | -$30.1M |
|
653
Charles River Laboratories
CRL
$13.4B
| $76.4M | 0.01% |
605,077
+15,868
| +3% | +$2.38M |
|
654
Parker-Hannifin
PH
$134B
| $76.2M | 0.01% |
587,401
+347,719
| +145% | +$62.9M |
|
655
Coca-Cola Consolidated
COKE
$12.7B
| $75.6M | 0.01% |
3,624,600
+554,890
| +18% | +$13.8M |
|
656
Welltower
WELL
$169B
| $75.4M | 0.01% |
1,645,958
+892,096
| +118% | +$65.8M |
|
|
FTCH
657
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $74.9M | 0.01% |
9,482,946
-872,306
| -8% | -$9.42M |
|
|
AIMT
658
DELISTED
Aimmune Therapeutics
AIMT
| $74.9M | 0.01% |
5,192,673
-429,865
| -8% | -$11M |
|
659
NVR
NVR
$17B
| $74.9M | 0.01% |
29,142
-48,333
| -62% | -$173M |
|
660
Helen of Troy
HELE
$699M
| $74.2M | 0.01% |
515,511
+4,051
| +0.8% | +$686K |
|
661
Liberty Latin America Class C
LILAK
$1.65B
| $74.2M | 0.01% |
8,452,259
-1,239,416
| -13% | -$16.7M |
|
662
Waste Management
WM
$89.6B
| $73.7M | 0.01% |
796,454
+62,496
| +9% | +$7.17M |
|
663
Exelon
EXC
$47B
| $73.3M | 0.01% |
2,791,204
+217,934
| +8% | +$6.85M |
|
|
PPD
664
DELISTED
PPD, Inc. Common Stock
PPD
| $73.2M | 0.01% |
+4,108,683
| New | +$103M |
|
665
Heritage Financial
HFWA
$1.23B
| $72.9M | 0.01% |
3,643,611
+68,213
| +2% | +$1.69M |
|
666
Generac Holdings
GNRC
$12.8B
| $72.4M | 0.01% |
776,970
+53,987
| +7% | +$5.56M |
|
667
Jazz Pharmaceuticals
JAZZ
$16B
| $72.4M | 0.01% |
725,531
+504,217
| +228% | +$65.2M |
|
668
CACI
CACI
$14.8B
| $72.1M | 0.01% |
341,520
+90,477
| +36% | +$22.5M |
|
669
UFP Industries
UFPI
$5.03B
| $72.1M | 0.01% |
1,937,626
+62,576
| +3% | +$2.87M |
|
670
Parsons
PSN
$5.08B
| $71.7M | 0.01% |
2,242,797
+50,889
| +2% | +$1.98M |
|
671
Vornado Realty Trust
VNO
$7.41B
| $71.6M | 0.01% |
1,977,906
-199,900
| -9% | -$11.4M |
|
|
RDUS
672
DELISTED
Radius Health, Inc.
RDUS
| $71.6M | 0.01% |
5,505,633
-334,661
| -6% | -$5.97M |
|
673
Primerica
PRI
$9.62B
| $71.6M | 0.01% |
808,799
+44,885
| +6% | +$5.13M |
|
674
LivaNova
LIVN
$4.53B
| $71.4M | 0.01% |
1,577,659
-1,188,862
| -43% | -$77M |
|
|
MTOR
675
DELISTED
MERITOR, Inc.
MTOR
| $71.4M | 0.01% |
5,385,479
+1,993,937
| +59% | +$43M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.